Skip to main content
Erschienen in: Metabolic Brain Disease 6/2015

01.12.2015 | Research Article

Brain microsomal fatty acid elongation is increased in abcd1-deficient mouse during active myelination phase

verfasst von: Masashi Morita, Misato Kawamichi, Yusuke Shimura, Kosuke Kawaguchi, Shiro Watanabe, Tsuneo Imanaka

Erschienen in: Metabolic Brain Disease | Ausgabe 6/2015

Einloggen, um Zugang zu erhalten

Abstract

The dysfunction of ABCD1, a peroxisomal ABC protein, leads to the perturbation of very long chain fatty acid (VLCFA) metabolism and is the cause of X-linked adrenoleukodystrophy. Abcd1-deficient mice exhibit an accumulation of saturated VLCFAs, such as C26:0, in all tissues, especially the brain. The present study sought to measure microsomal fatty acid elongation activity in the brain of wild-type (WT) and abcd1-deficient mice during the course of development. The fatty acid elongation activity in the microsomal fraction was measured by the incorporation of [2-14C]malonyl-CoA into fatty acids in the presence of C16:0-CoA or C20:0-CoA. Cytosolic fatty acid synthesis activity was completely inhibited by the addition of N-ethylmaleimide (NEM). The microsomal fatty acid elongation activity in the brain was significantly high at 3 weeks after birth and decreased substantially at 3 months after birth. Furthermore, we detected two different types of microsomal fatty acid elongation activity by using C16:0-CoA or C20:0-CoA as the substrate and found the activity toward C20:0-CoA in abcd1-deficient mice was higher than the WT 3-week-old animals. These results suggest that during the active myelination phase the microsomal fatty acid elongation activity is stimulated in abcd1-deficient mice, which in turn perturbs the lipid composition in myelin.
Literatur
Zurück zum Zitat Asheuer M, Bieche I, Laurendeau I, et al (2005) Decreased expression of ABCD4 and BG1 genes early in the pathogenesis of X-linked adrenoleukodystrophy. Hum Mol Genet 14:1293–1303CrossRefPubMed Asheuer M, Bieche I, Laurendeau I, et al (2005) Decreased expression of ABCD4 and BG1 genes early in the pathogenesis of X-linked adrenoleukodystrophy. Hum Mol Genet 14:1293–1303CrossRefPubMed
Zurück zum Zitat Bligh EG, Dyer WJ (1959) A rapid method of total lipid extraction and purification. Can J Biochem Phys 37:911–917CrossRef Bligh EG, Dyer WJ (1959) A rapid method of total lipid extraction and purification. Can J Biochem Phys 37:911–917CrossRef
Zurück zum Zitat Bourre JM, Pollet SA, Daudu OL, Baumann NA (1973) Evolution, in mouse brain microsomes, of lipids and their constituents during myelination. Brain Res 51:225–239CrossRefPubMed Bourre JM, Pollet SA, Daudu OL, Baumann NA (1973) Evolution, in mouse brain microsomes, of lipids and their constituents during myelination. Brain Res 51:225–239CrossRefPubMed
Zurück zum Zitat Bourre JM, Daudu OL, Baymann NA (1975) Biosynthesis of lignoceric acid from behenyl-CoA in mouse brain microsomes. Comparison between normal and Quaking mutant. Biochem Biophys Res Commun 63:1027–1034CrossRefPubMed Bourre JM, Daudu OL, Baymann NA (1975) Biosynthesis of lignoceric acid from behenyl-CoA in mouse brain microsomes. Comparison between normal and Quaking mutant. Biochem Biophys Res Commun 63:1027–1034CrossRefPubMed
Zurück zum Zitat Bourre JM, Paturneau-Jouas MY, Daudu OL, Baumann NA (1977) Lignoceric acid biosynthesis in the developing brain. Activities of mitochondrial acetyl-CoA-dependent synthesis and microsomal malonyl-CoA chain-elongating system in relation to myelination. Comparison between normal mouse and dysmyelinating mutants (quaking and jimpy). Eur J Biochem 72:41–47CrossRefPubMed Bourre JM, Paturneau-Jouas MY, Daudu OL, Baumann NA (1977) Lignoceric acid biosynthesis in the developing brain. Activities of mitochondrial acetyl-CoA-dependent synthesis and microsomal malonyl-CoA chain-elongating system in relation to myelination. Comparison between normal mouse and dysmyelinating mutants (quaking and jimpy). Eur J Biochem 72:41–47CrossRefPubMed
Zurück zum Zitat Brown 3rd FR, Chen WW, Kirschner DA, et al (1983) Myelin membrane from adrenoleukodystrophy brain white matter–biochemical properties. J Neurochem 41:341–348CrossRefPubMed Brown 3rd FR, Chen WW, Kirschner DA, et al (1983) Myelin membrane from adrenoleukodystrophy brain white matter–biochemical properties. J Neurochem 41:341–348CrossRefPubMed
Zurück zum Zitat Fourcade S, Ruiz M, Camps C, et al (2009) A key role for the peroxisomal ABCD2 transporter in fatty acid homeostasis. Am J Physiol Endocrinol Metab 296:E211–E221CrossRefPubMed Fourcade S, Ruiz M, Camps C, et al (2009) A key role for the peroxisomal ABCD2 transporter in fatty acid homeostasis. Am J Physiol Endocrinol Metab 296:E211–E221CrossRefPubMed
Zurück zum Zitat Heinzer AK, Watkins PA, Lu JF, et al (2003) A very long-chain acyl-CoA synthetase-deficient mouse and its relevance to X-linked adrenoleukodystrophy. Hum Mol Genet 12:1145–1154CrossRefPubMed Heinzer AK, Watkins PA, Lu JF, et al (2003) A very long-chain acyl-CoA synthetase-deficient mouse and its relevance to X-linked adrenoleukodystrophy. Hum Mol Genet 12:1145–1154CrossRefPubMed
Zurück zum Zitat Ho JK, Moser H, Kishimoto Y, Hamilton JA (1995) Interactions of a very long chain fatty acid with model membranes and serum albumin. Implications for the pathogenesis of adrenoleukodystrophy. J Clin Invest 96:1455–1463PubMedCentralCrossRefPubMed Ho JK, Moser H, Kishimoto Y, Hamilton JA (1995) Interactions of a very long chain fatty acid with model membranes and serum albumin. Implications for the pathogenesis of adrenoleukodystrophy. J Clin Invest 96:1455–1463PubMedCentralCrossRefPubMed
Zurück zum Zitat Imanaka T, Shiina Y, Takano T, Hashimoto T, Osumi T (1996) Insertion of the 70-kDa peroxisomal membrane protein into peroxisomal membranes in vivo and in vitro. J Biol Chem 271:3706–3713CrossRefPubMed Imanaka T, Shiina Y, Takano T, Hashimoto T, Osumi T (1996) Insertion of the 70-kDa peroxisomal membrane protein into peroxisomal membranes in vivo and in vitro. J Biol Chem 271:3706–3713CrossRefPubMed
Zurück zum Zitat Jang J, Kang HC, Kim HS, et al (2011) Induced pluripotent stem cell models from X-linked adrenoleukodystrophy patients. Ann Neurol 70:402–409CrossRefPubMed Jang J, Kang HC, Kim HS, et al (2011) Induced pluripotent stem cell models from X-linked adrenoleukodystrophy patients. Ann Neurol 70:402–409CrossRefPubMed
Zurück zum Zitat Kemp S, Wanders R (2010) Biochemical aspects of X-linked adrenoleukodystrophy. Brain Pathol 20:831–837CrossRefPubMed Kemp S, Wanders R (2010) Biochemical aspects of X-linked adrenoleukodystrophy. Brain Pathol 20:831–837CrossRefPubMed
Zurück zum Zitat Kemp S. Valianpour F, Denis S et al (2005) Elongation of very long-chain fatty acids is enhanced in X-linked adrenoleukodystrophy. Mol Genet Metab 84:144–151.CrossRefPubMed Kemp S. Valianpour F, Denis S et al (2005) Elongation of very long-chain fatty acids is enhanced in X-linked adrenoleukodystrophy. Mol Genet Metab 84:144–151.CrossRefPubMed
Zurück zum Zitat Kobayashi T, Shinnoh N, Kondo A, Yamada T (1997) Adrenoleukodystrophy protein-deficient mice represent abnormality of very long chain fatty acid metabolism. Biochem Biophys Res Commun 232:631–636CrossRefPubMed Kobayashi T, Shinnoh N, Kondo A, Yamada T (1997) Adrenoleukodystrophy protein-deficient mice represent abnormality of very long chain fatty acid metabolism. Biochem Biophys Res Commun 232:631–636CrossRefPubMed
Zurück zum Zitat Lazo O, Singh AK, Singh I (1991) Postnatal development and isolation of peroxisomes from brain. J Neurochem 56:1343–1353CrossRefPubMed Lazo O, Singh AK, Singh I (1991) Postnatal development and isolation of peroxisomes from brain. J Neurochem 56:1343–1353CrossRefPubMed
Zurück zum Zitat Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275PubMed Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275PubMed
Zurück zum Zitat Moon YA, Shah NA, Mohapatra S, Warrington JA, Horton JD (2001) Identification of a mammalian long chain fatty acyl elongase regulated by sterol regulatory element-binding proteins. J Biol Chem 276:45358–45366CrossRefPubMed Moon YA, Shah NA, Mohapatra S, Warrington JA, Horton JD (2001) Identification of a mammalian long chain fatty acyl elongase regulated by sterol regulatory element-binding proteins. J Biol Chem 276:45358–45366CrossRefPubMed
Zurück zum Zitat Morita M, Imanaka T (2012) Peroxisomal ABC transporters: structure, function and role in disease. Biochim Biophys Acta 1822:1387–1396CrossRefPubMed Morita M, Imanaka T (2012) Peroxisomal ABC transporters: structure, function and role in disease. Biochim Biophys Acta 1822:1387–1396CrossRefPubMed
Zurück zum Zitat Morita M, Takahashi I, Kanai M, et al (2005) Baicalein 5,6,7-trimethyl ether, a flavonoid derivative, stimulates fatty acid β-oxidation in skin fibroblasts of X-linked adrenoleukodystrophy. FEBS Lett 579:409–414CrossRefPubMed Morita M, Takahashi I, Kanai M, et al (2005) Baicalein 5,6,7-trimethyl ether, a flavonoid derivative, stimulates fatty acid β-oxidation in skin fibroblasts of X-linked adrenoleukodystrophy. FEBS Lett 579:409–414CrossRefPubMed
Zurück zum Zitat Morita M, Shimozawa N, Kashiwayama Y, Suzuki Y, Imanaka T (2011) ABC subfamily D proteins and very long chain fatty acid metabolism as novel targets in adrenoleukodystrophy. Curr Drug Targets 12:694–706CrossRefPubMed Morita M, Shimozawa N, Kashiwayama Y, Suzuki Y, Imanaka T (2011) ABC subfamily D proteins and very long chain fatty acid metabolism as novel targets in adrenoleukodystrophy. Curr Drug Targets 12:694–706CrossRefPubMed
Zurück zum Zitat Morita M, Kobayashi J, Yamazaki K, et al (2013) A novel double mutation in the ABCD1 gene in a patient with X-linked adrenoleukodystrophy: analysis of the stability and function of the mutant ABCD1 protein. JIMD Rep 10:95–102PubMedCentralCrossRefPubMed Morita M, Kobayashi J, Yamazaki K, et al (2013) A novel double mutation in the ABCD1 gene in a patient with X-linked adrenoleukodystrophy: analysis of the stability and function of the mutant ABCD1 protein. JIMD Rep 10:95–102PubMedCentralCrossRefPubMed
Zurück zum Zitat Moser HW (1997) Adrenoleukodystrophy: phenotype, genetics, pathogenesis and therapy. Brain 120:1485–1508CrossRefPubMed Moser HW (1997) Adrenoleukodystrophy: phenotype, genetics, pathogenesis and therapy. Brain 120:1485–1508CrossRefPubMed
Zurück zum Zitat Mosser J, Douar AM, Sarde CO, et al (1993) Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters. Nature 361:726–730CrossRefPubMed Mosser J, Douar AM, Sarde CO, et al (1993) Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters. Nature 361:726–730CrossRefPubMed
Zurück zum Zitat Murad S, Kishimoto Y (1978) Chain elongation of fatty acid in brain: a comparison of mitochondrial and microsomal enzyme activities. Arch Biochem Biophys 185:300–306CrossRefPubMed Murad S, Kishimoto Y (1978) Chain elongation of fatty acid in brain: a comparison of mitochondrial and microsomal enzyme activities. Arch Biochem Biophys 185:300–306CrossRefPubMed
Zurück zum Zitat Ofman R, Dijkstra IM, van Roermund CW, et al (2010) The role of ELOVL1 in very long-chain fatty acid homeostasis and X-linked adrenoleukodystrophy. EMBO Mol Med 2:90–97PubMedCentralCrossRefPubMed Ofman R, Dijkstra IM, van Roermund CW, et al (2010) The role of ELOVL1 in very long-chain fatty acid homeostasis and X-linked adrenoleukodystrophy. EMBO Mol Med 2:90–97PubMedCentralCrossRefPubMed
Zurück zum Zitat Paintlia AS, Gilg AG, Khan M, Singh AK, Barbosa E, Singh I (2003) Correlation of very long chain fatty acid accumulation and inflammatory disease progression in childhood X-ALD: implications for potential therapies. Neurobiol Dis 14:425–439CrossRefPubMed Paintlia AS, Gilg AG, Khan M, Singh AK, Barbosa E, Singh I (2003) Correlation of very long chain fatty acid accumulation and inflammatory disease progression in childhood X-ALD: implications for potential therapies. Neurobiol Dis 14:425–439CrossRefPubMed
Zurück zum Zitat Poulos A, Usher S, Paton BC (1993) Fatty acid synthesis from [2-14C]acetate in normal and peroxisome-deficient (Zellweger) fibroblasts. Lipids 28:97–102CrossRefPubMed Poulos A, Usher S, Paton BC (1993) Fatty acid synthesis from [2-14C]acetate in normal and peroxisome-deficient (Zellweger) fibroblasts. Lipids 28:97–102CrossRefPubMed
Zurück zum Zitat Schackmann MJ, Ofman R, Dijkstra IM, Wanders RJ, Kemp S (2014) Enzymatic characterization of ELOVL1, a key enzyme in very long-chain fatty acid synthesis. Biochim Biophys Acta 1851:231–237CrossRefPubMed Schackmann MJ, Ofman R, Dijkstra IM, Wanders RJ, Kemp S (2014) Enzymatic characterization of ELOVL1, a key enzyme in very long-chain fatty acid synthesis. Biochim Biophys Acta 1851:231–237CrossRefPubMed
Zurück zum Zitat Shinnoh N, Yamada T, Yoshimura T, et al (1995) Adrenoleukodystrophy: the restoration of peroxisomal β-oxidation by transfection of normal cDNA. Biochem Biophys Res Commun 210:830–836CrossRefPubMed Shinnoh N, Yamada T, Yoshimura T, et al (1995) Adrenoleukodystrophy: the restoration of peroxisomal β-oxidation by transfection of normal cDNA. Biochem Biophys Res Commun 210:830–836CrossRefPubMed
Zurück zum Zitat Street JM, Johnson DW, Singh H, Poulos A (1989) Metabolism of saturated and polyunsaturated fatty acids by normal and Zellweger syndrome skin fibroblasts. Biochem J 260:647–655PubMedCentralCrossRefPubMed Street JM, Johnson DW, Singh H, Poulos A (1989) Metabolism of saturated and polyunsaturated fatty acids by normal and Zellweger syndrome skin fibroblasts. Biochem J 260:647–655PubMedCentralCrossRefPubMed
Zurück zum Zitat Street JM, Singh H, Poulos A (1990) Metabolism of saturated and polyunsaturated very-long-chain fatty acids in fibroblasts from patients with defects in peroxisomal β-oxidation. Biochem J 269:671–677PubMedCentralCrossRefPubMed Street JM, Singh H, Poulos A (1990) Metabolism of saturated and polyunsaturated very-long-chain fatty acids in fibroblasts from patients with defects in peroxisomal β-oxidation. Biochem J 269:671–677PubMedCentralCrossRefPubMed
Zurück zum Zitat Tsuji S, Ohno T, Miyatake T, Suzuki A, Yamakawa T (1984) Fatty acid elongation activity in fibroblasts from patients with adrenoleukodystrophy (ALD). J Biochem 96:1241–1247PubMed Tsuji S, Ohno T, Miyatake T, Suzuki A, Yamakawa T (1984) Fatty acid elongation activity in fibroblasts from patients with adrenoleukodystrophy (ALD). J Biochem 96:1241–1247PubMed
Zurück zum Zitat Wang Y, Botolin D, Xu J, et al (2006) Regulation of hepatic fatty acid elongase and desaturase expression in diabetes and obesity. J Lipid Res 47:2028–2041PubMedCentralCrossRefPubMed Wang Y, Botolin D, Xu J, et al (2006) Regulation of hepatic fatty acid elongase and desaturase expression in diabetes and obesity. J Lipid Res 47:2028–2041PubMedCentralCrossRefPubMed
Metadaten
Titel
Brain microsomal fatty acid elongation is increased in abcd1-deficient mouse during active myelination phase
verfasst von
Masashi Morita
Misato Kawamichi
Yusuke Shimura
Kosuke Kawaguchi
Shiro Watanabe
Tsuneo Imanaka
Publikationsdatum
01.12.2015
Verlag
Springer US
Erschienen in
Metabolic Brain Disease / Ausgabe 6/2015
Print ISSN: 0885-7490
Elektronische ISSN: 1573-7365
DOI
https://doi.org/10.1007/s11011-015-9701-1

Weitere Artikel der Ausgabe 6/2015

Metabolic Brain Disease 6/2015 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.